ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)

ClinicalTrials.gov ID: NCT03823300

Public ClinicalTrials.gov record NCT03823300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (LUCERNE)

Study identification

NCT ID
NCT03823300
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
658 participants

Conditions and interventions

Interventions

  • Aflibercept Drug
  • Faricimab Drug
  • Sham Procedure Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2019
Primary completion
Oct 4, 2020
Completion
Jan 6, 2022
Last update posted
Jul 10, 2025

2019 – 2022

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Associated Retina Consultants Phoenix Arizona 85020
Arizona Retina and Vitreous Consultants Phoenix Arizona 85021
Northern California Retina Vitreous Associates Mountain View California 94040
Retinal Consultants Med Group Sacramento California 95825
Orange County Retina Med Group Santa Ana California 92705
California Retina Consultants Santa Barbara California 93103
Colorado Retina Associates, PC Golden Colorado 80401
Retina Group of Florida Fort Lauderdale Florida 33308
Retina Care Specialists Palm Beach Gardens Florida 33410
Southern Vitreoretinal Assoc Tallahassee Florida 32308
Retina Associates of Florida, LLC Tampa Florida 33609
Southeast Retina Center Augusta Georgia 30909
Georgia Retina PC Marietta Georgia 30060
Retina Consultants of Hawaii ‘Aiea Hawaii 96701
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Prairie Retina Center Springfield Illinois 62704
Raj K. Maturi, MD PC Indianapolis Indiana 46290
Wolfe Eye Clinic West Des Moines Iowa 50266
Maine Eye Center Portland Maine 04101
The Retina Care Center Baltimore Maryland 21209
Cumberland Valley Retina PC Hagerstown Maryland 21740
Retina Specialists Towson Maryland 21204
Ophthalmic Consultants of Boston Boston Massachusetts 02114
VitreoRetinal Surgery, PLLC. Minneapolis Minnesota 55435
Mid Atlantic Retina - Wills Eye Hospital Cherry Hill New Jersey 08034
Island Retina Shirley New York 11967
Retina Assoc of Cleveland Inc Cleveland Ohio 44122
The Ohio State University Havener Eye Institute Columbus Ohio 43212
Midwest Retina Dublin Ohio 43016
Palmetto Retina Center West Columbia South Carolina 29169
Southeastern Retina Associates Chattanooga Chattanooga Tennessee 37421
Retina Res Institute of Texas Abilene Texas 79606
Austin Retina Associates Austin Texas 78705
Austin Clinical Research LLC Austin Texas 78750
Retina Center of Texas Grapevine Texas 76051
Retina Consultants of Houston The Woodlands Texas 77384
Strategic Clinical Research Group, LLC Willow Park Texas 76087
Retina Associates of Utah, PLLC Murray Utah 84107
Piedmont Eye Center Lynchburg Virginia 24502
Wagner Kapoor Institute Norfolk Virginia 23502
Pacific Northwest Retina Silverdale Washington 98383

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 96 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03823300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03823300 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →